Earli

Earli is a cancer treatment device developer that focuses on identifying natural biomarkers for cancer detection. The company's device works by triggering cancer cells to generate synthetic biomarkers that are not typically found in the human body. These biomarkers can then be detected in blood, urine or breath samples, which allows for the tracking and elimination of cancer. Earli's technology provides quick treatment response data directly from the cancer, enabling personalized treatment plans and early metastasis detection.